Agilent Technologies

Yahoo Finance • 4 days ago

Elemental Analysis Market Research and Global Forecasts Report 2025-2026 & 2030: Adoption Driven by Rising Demand in Emerging Economies and Expanding Global Water Quality Monitoring Mandates

Company Logo The elemental analysis market is set to grow from USD 4.51 billion in 2025 to USD 6.48 billion by 2030, driven by regulatory pressures and industrial needs. The adoption of high-sensitivity technologies like ICP-OES is accele... Full story

Yahoo Finance • 5 days ago

The Bull Case For Agilent Technologies (A) Could Change Following Exclusive FDA Approval Of Its KEYTRUDA Test

Agilent Technologies has recently received U.S. FDA approval for its PD-L1 IHC 22C3 pharmDx assay as the only companion diagnostic to identify esophageal and gastroesophageal junction carcinoma patients eligible for treatment with KEYTRUDA... Full story

Yahoo Finance • 7 days ago

Agilent Technologies Names Michael Buckner as CLO

By Karen Roman Agilent Technologies, Inc. (NYSE: A) said it designated Michael Buckner as Chief Legal Officer, having previously served at Danaher as Vice President, Deputy General Counsel, and Chief M&A Counsel. Mr. Buckner has nearly 3... Full story

Yahoo Finance • 19 days ago

Labcorp Launches FDA-Approved Companion Diagnostic to Identify Patients with Ovarian Cancer Eligible for KEYTRUDA®

BURLINGTON, N.C., April 22, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide availability of Agilent Technologies' PD-L1 IHC 22C3 pharmDx, the only... Full story

Yahoo Finance • 20 days ago

Jim Cramer on Aehr: “I Wish I Didn’t Have to Say It, But We Have to Wait”

Aehr Test Systems, Inc. (NASDAQ:AEHR) was among Jim Cramer’s recent stock calls on Mad Money. A caller sought Cramer’s take on the stock, and here’s what he had to say in response: You know, testing memory has always been something that A... Full story

Yahoo Finance • 22 days ago

Agilent Cancer Research Push Spurs Collaboration Focus And Investor Reassessment

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Agilent Technologies (NYSE:A) highlighted new technologies and scientific data aimed at advancing cancer research. The comp... Full story

Yahoo Finance • 24 days ago

3 Reasons A is Risky and 1 Stock to Buy Instead

Over the past six months, Agilent’s stock price fell to $118.28. Shareholders have lost 16.7% of their capital, which is disappointing considering the S&P 500 has climbed by 5.4%. This may have investors wondering how to approach the situa... Full story

Yahoo Finance • 26 days ago

Bank of America GAAP EPS of $1.11 beats by $0.09, revenue of $30.3B beats by $350M

* Bank of America press release [https://d1io3yog0oux5.cloudfront.net/_d4ae35015e306c7913d07024bace714a/bankofamerica/db/806/10536/earnings_release/The+Press+Release_1Q26.pdf] (BAC [https://seekingalpha.com/symbol/BAC]): Q1 GAAP EPS of $... Full story

Yahoo Finance • 28 days ago

3 S&P 500 Stocks with Warning Signs

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitor... Full story

Yahoo Finance • last month

Founder Group Limited regains Nasdaq compliance on public float requirement

* Founder Group (FGL [https://seekingalpha.com/symbol/FGL]) on Friday said it has regained compliance with Nasdaq’s minimum publicly held shares requirement. * The company said it received confirmation from Nasdaq on April 9 that it me... Full story

Yahoo Finance • last month

[Latest] Global Environmental Mass Spectrometry Market Size/Share Worth USD 6.47 Billion by 2035 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Environmental Mass Spectrometry Market size & share revenue was valued at approximat... Full story

Yahoo Finance • last month

Agilent receives FDA approval for PD-L1 1HC 22C3 pharmDx

Agilent Technologies (A) announced that it has received U.S. Food and Drug Administration approval for PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to aid in identifying patients with esophageal or gastroesophageal junctio... Full story

Yahoo Finance • 2 months ago

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma

Test enables identification of patients whose tumors express PD-L1 for potential treatment with KEYTRUDA® (pembrolizumab)1, 2 SANTA CLARA, Calif., March 26, 2026--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that i... Full story

Yahoo Finance • 2 months ago

Emerald Growth Equity Strategy Sold Agilent (A) Due to Compression in the Margin of Safety

Emerald Wealth Partners, an independent asset and wealth management firm based in Zurich, released its Q4 2025 investor letter for the “Growth Equity Strategy.” A copy of the letter is available to download here. In 2025, the strategy retu... Full story

Yahoo Finance • 2 months ago

Most oversold large-cap stocks on Wall Street

[Relative Strength Index (<a href='https://seekingalpha.com/symbol/RSI' title='Rush Street Interactive, Inc.'>RSI</a>) symbolizes the importance of understanding market momentum and using technical analysis tools to make informed investmen... Full story

Yahoo Finance • 2 months ago

Citi Flags Agilent Technologies, Cuts Icon PLC Target, and More

Quick Read Citi is positioning selectively across life sciences by favoring recovery names with clear catalysts while avoiding companies navigating accounting uncertainty, with Agilent’s pending Biocare deal removal expected to drive mult... Full story

Yahoo Finance • 2 months ago

Jim Cramer on Agilent Technologies: “I Don’t Think You Need It”

Agilent Technologies, Inc. (NYSE:A) is one of the stocks on which Jim Cramer expressed his thoughts. A caller asked if the stock will ever come back, and here’s what Cramer had to say in response: You know, they do so much test and measur... Full story

Yahoo Finance • 2 months ago

Agilent to acquire Biocare Medical for $950M, expanding pathology portfolio

* Agilent Technologies (A [https://seekingalpha.com/symbol/A]) has entered into a definitive agreement to acquire [https://seekingalpha.com/pr/20428347-agilent-to-acquire-biocare-medical-a-global-leader-in-clinical-and-research-pathology... Full story

Yahoo Finance • 2 months ago

Agilent Technologies, Inc. (A) Price Target Cut to $155 at Baird

Agilent Technologies, Inc. (NYSE:A) is among the 10 Stocks That Could Skyrocket in 2026.Agilent Technologies, Inc. (A) Price Target Cut to $155 at Baird On February 26, Baird lowered the firm’s price target on Agilent Technologies, Inc. (... Full story

Yahoo Finance • 2 months ago

[Latest] Global Laboratory Informatics Market Size/Share Worth USD 8.21 Billion by 2035 at a 5.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Laboratory Informatics Market size & share revenue was valued at approximately USD 4... Full story